Zepbound tracker
A once-a-week record for Zepbound®: log each injection with its site, follow your weight beside it, and keep count of the pens or vials you have left.
Not affiliated with or endorsed by Novo Nordisk or Eli Lilly. Wegovy® and Ozempic® are trademarks of Novo Nordisk A/S; Zepbound® and Mounjaro® are trademarks of Eli Lilly and Company. This page is a record-keeping tool. It doesn’t give dosing or medical advice; follow your prescriber and the product’s label.
Log a Zepbound injection
The name is filled in; the amount is yours to enter from your prescription.
Your injection day
Weight
Pens and vials on hand
No items yet.
Everything here is the same record as the full tracker, stored in this browser only. Export or back it up from its Data tab.
What the Zepbound label says
From the ZEPBOUND prescribing information
- Ingredient: tirzepatide, a GIP and GLP-1 receptor agonist.
- Approved uses, with a reduced-calorie diet and increased physical activity: reducing excess body weight and keeping it off long term in adults with obesity, or adults with overweight and at least one weight-related condition; and treating moderate to severe obstructive sleep apnea in adults with obesity.
- Injected under the skin once weekly.
- Injection areas: abdomen or thigh, or the back of the upper arm when someone else gives the injection; the label says to rotate the site with each dose.
- Forms: single-dose pens, single-dose vials, multi-dose vials and single-patient-use KwikPens (the last two hold four doses each).
- The label says not to use it together with other tirzepatide-containing products or any GLP-1 receptor agonist.
Source: ZEPBOUND (tirzepatide) prescribing information, Eli Lilly and Company, DailyMed (version of August 28, 2026). Amounts and dose changes are deliberately left out; they’re for your prescriber and the full label.
A weekly log with weight beside it
Save your injection day once and the calendar shows every week: logged, skipped or not logged yet. Weigh in on the same day each week so the trend compares like with like. The chart shows only what you entered; it can’t tell you why your weight changed.
Keeping pen and vial records
Zepbound comes in several forms, so record yours the way it’s counted. Single-dose pens and vials: unit “count”, automatic deduction on, one off per logged injection. KwikPens and multi-dose vials: count containers with automatic deduction off, and adjust when you start a new one. The history shows every change.
Zepbound or Mounjaro?
Both contain tirzepatide but have different labels and approved uses. If yours is prescribed for type 2 diabetes, the Mounjaro tracker adds glucose and A1C fields.
Prefer reminders on your phone? Peptide Library’s GLP-1 tracker handles weekly reminders and sync.
Label sources
Label facts on this page come only from FDA-approved prescribing information, checked November 8, 2026.
Questions
- What does the Zepbound tracker record?
- Each weekly injection (date, time, the amount you enter and the site), your weight, and how many pens or vials you have. The name starts as Zepbound; you can change it.
- Will it tell me when to change my Zepbound dose?
- No. This site never suggests amounts or dose changes. The amount field is always yours to fill in from your prescription.
- How do I track single-dose pens or vials?
- Add them on the inventory panel with the unit “count”. With “Take logged amounts off” on, each taken entry named Zepbound removes one.
- What about the KwikPen or multi-dose vial?
- The label describes both as holding four doses. Count them with automatic deduction off, and use Adjust (“new pen started”) when you open the next one.
- Is this site connected to Eli Lilly?
- No. Best Peptide Tracker is published by Peptide Library and isn’t affiliated with or endorsed by Eli Lilly and Company. Zepbound® is a trademark of Eli Lilly and Company.